Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luteal phase ovarian stimulation with follitropin delta and dydrogesterone: randomized crossover pilot in oocyte donors
2022-003049-37Phase 4Active
- Sponsor
- UZ Brussel
- Start
- Oct 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of follitropin delta and dydrogesterone (2 arms), sponsored by UZ Brussel. Primary endpoint: total number of retrieved cumulus-oocyte complexes (COCs). Started Oct 2022; status: active.
02
Drugs
follitropin deltadydrogesterone
Beyond the preview
Go deeper on 2022-003049-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003049-37.